Your browser is no longer supported. Please, upgrade your browser.
Settings
VCYT Veracyte, Inc. daily Stock Chart
VCYT [NASD]
Veracyte, Inc.
Index- P/E- EPS (ttm)-0.42 Insider Own0.60% Shs Outstand47.62M Perf Week7.07%
Market Cap1.31B Forward P/E- EPS next Y-0.21 Insider Trans-86.40% Shs Float45.70M Perf Month12.03%
Income-15.70M PEG- EPS next Q-0.11 Inst Own86.00% Short Float3.76% Perf Quarter27.29%
Sales101.50M P/S12.93 EPS this Y32.00% Inst Trans2.07% Short Ratio2.40 Perf Half Y111.26%
Book/sh2.03 P/B13.58 EPS next Y32.30% ROA-14.70% Target Price28.33 Perf Year242.91%
Cash/sh1.42 P/C19.36 EPS next 5Y- ROE-23.40% 52W Range7.96 - 28.18 Perf YTD119.16%
Dividend- P/FCF- EPS past 5Y12.70% ROI-21.20% 52W High-2.16% Beta0.98
Dividend %- Quick Ratio6.10 Sales past 5Y33.30% Gross Margin66.80% 52W Low246.36% ATR1.29
Employees270 Current Ratio6.30 Sales Q/Q47.50% Oper. Margin-15.00% RSI (14)63.97 Volatility5.14% 4.63%
OptionableYes Debt/Eq0.16 EPS Q/Q82.60% Profit Margin-15.50% Rel Volume0.45 Prev Close27.93
ShortableYes LT Debt/Eq0.15 EarningsJul 30 AMC Payout- Avg Volume715.56K Price27.57
Recom1.00 SMA2011.04% SMA5012.95% SMA20060.04% Volume325,195 Change-1.29%
Nov-29-18Downgrade Janney Buy → Neutral
Oct-31-18Upgrade Janney Neutral → Buy
Nov-07-17Downgrade Piper Jaffray Overweight → Neutral
Nov-07-17Downgrade Janney Buy → Neutral
Aug-31-17Resumed BTIG Research Buy $13
Nov-14-16Resumed Leerink Partners Outperform $12
Dec-18-15Initiated Cantor Fitzgerald Buy $13
Jun-11-15Reiterated Leerink Partners Outperform $11 → $13
Nov-26-13Initiated William Blair Outperform
Jun-14-19 02:59PM  7 Top-Rated Biotech Stocks to Invest In Today InvestorPlace
09:49AM  GE wants to unload the portfolio of its Menlo Park venture arm American City Business Journals
Jun-10-19 04:15PM  Veracyte Announces New Publication of Data Demonstrating Real-World Performance of the Afirma GSC in Thyroid Cancer Diagnosis Business Wire
Jun-07-19 09:26AM  Riskalyze hires Bay Area tech executive as CFO American City Business Journals
09:18AM  New Strong Buy Stocks for June 7th Zacks
Jun-01-19 02:15PM  Veracyte Announces New Data Showing Potential of Afirma Genomic Test to Guide Targeted Treatment for Medullary Thyroid Cancer Concurrent with Diagnosis Business Wire
May-30-19 12:49PM  Before You Buy Veracyte, Inc. (NASDAQ:VCYT), Consider Its Volatility Simply Wall St.
May-29-19 04:20PM  Veracyte Announces Participation in Two Upcoming Investor Conferences Business Wire
May-23-19 08:00AM  Veracyte Announces New Data Demonstrating Afirma Xpression Atlass Potential to Inform Treatment Selection for Patients with Medullary Thyroid Cancer to Be Presented at 2019 ASCO Annual Meeting Business Wire
May-20-19 08:00AM  Veracyte Unveils Next-Generation Percepta Genomic Sequencing Classifier for Improved Lung Cancer Diagnosis Business Wire
May-14-19 08:30AM  Veracyte Names Sangeeta Bhorade, M.D., Medical Director of Pulmonology Business Wire +5.27%
May-11-19 12:46PM  Hedge Funds Have Never Been This Bullish On Veracyte Inc (VCYT) Insider Monkey
May-09-19 04:20PM  Veracyte to Present at the UBS Global Healthcare Conference Business Wire
07:46AM  These 3 revolutionary genomics companies are changing lives for patients and investors MarketWatch
May-07-19 04:15PM  Veracyte Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares Business Wire -6.67%
May-04-19 03:05AM  Edited Transcript of VCYT earnings conference call or presentation 30-Apr-19 9:00pm GMT Thomson Reuters StreetEvents
May-02-19 07:57PM  Veracyte Announces Pricing of Public Offering of 5,500,000 Shares of Common Stock Business Wire
May-01-19 04:33PM  Veracyte Announces Proposed Public Offering of Common Stock Business Wire +10.06%
07:39AM  The Daily Biotech Pulse: Nabriva Stumbles At FDA Hurdle, Gilead CFO To Retire, Eisai Ends Collaboration With Purdue Benzinga
Apr-30-19 10:44PM  Veracyte (VCYT) Q1 2019 Earnings Call Transcript Motley Fool
06:57PM  Veracyte: 1Q Earnings Snapshot Associated Press
04:15PM  Veracyte Announces First Quarter 2019 Financial Results Business Wire
03:00PM  Veracyte, Inc. to Host Earnings Call ACCESSWIRE
Apr-23-19 10:32AM  Will Veracyte (VCYT) Report Negative Earnings Next Week? What You Should Know Zacks
08:08AM  The Daily Biotech Pulse: FDA Accepts Alder's Migraine Drug Application, Gritstone Offering, Lilly's Chinese Sale Benzinga
Apr-22-19 04:15PM  Veracyte Receives Regulatory Authorization to Offer Envisia Genomic Classifier for Patients in New York State Business Wire
08:30AM  Veracyte Names Alfred Bowie, Jr., Ph.D. as Vice President, Corporate and Business Development Business Wire
Apr-19-19 01:34PM  Can You Imagine How Chuffed Veracyte's (NASDAQ:VCYT) Shareholders Feel About Its 297% Share Price Gain? Simply Wall St.
Apr-09-19 03:33PM  These Cannabis and China ETFs are Leading the 2019 Rally Investopedia
Apr-08-19 07:30AM  Veracyte Announces Publication Highlighting Afirma GSCs Ability to Rule Out Cancer in Challenging Thyroid Nodule Subtype Business Wire
Apr-03-19 08:30AM  Veracyte to Release First Quarter 2019 Financial Results on April 30, 2019 Business Wire
Apr-01-19 06:46PM  Veracyte Announces Data Published in The Lancet Respiratory Medicine Demonstrate that the Envisia Genomic Classifier Improves Diagnosis of IPF Business Wire
Mar-28-19 04:15PM  Veracyte Announces Participation in the 18th Annual Needham Healthcare Conference Business Wire +5.88%
09:49AM  3 Small Biotech Stocks Hitting New Highs Investopedia
Mar-27-19 07:00AM  Research Report Identifies Alamos Gold, Thermo Fisher Scientific, Veracyte, Air Lease, Carlisle Companies, and Medidata Solutions with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire -5.89%
Mar-25-19 04:15PM  Veracyte Announces New Afirma Xpression Atlas Data that Advance Genomic Understanding of Medullary Thyroid Cancer Business Wire +5.31%
Mar-22-19 09:36AM  Will Veracyte Continue to Surge Higher? Zacks
Mar-19-19 07:30AM  Veracyte Announces Sponsorship of the Climb to Fight Cancers Team Kilimanjaro Expedition Business Wire
Mar-18-19 07:30AM  Veracyte Announces New Afirma Xpression Atlas Data on Medullary Thyroid Cancer to Be Presented at ENDO 2019 Business Wire
Mar-14-19 01:10PM  Veracyte, Inc.s (NASDAQ:VCYT) Shift From Loss To Profit Simply Wall St.
11:15AM  Veracyte (VCYT) Reports Q4 Loss, Tops Revenue Estimates Zacks
Mar-05-19 10:53AM  Zacks.com featured highlights include: Radiant, Great Lakes, Clarus, Veracyte and First BanCorp Zacks
Mar-04-19 08:30AM  Veracyte Receives Final Medicare Coverage Policy for Envisia Genomic Classifier Business Wire
07:22AM  5 Stocks With Recent Price Strength to Maximize Your Gains Zacks
Mar-01-19 06:20AM  Edited Transcript of VCYT earnings conference call or presentation 25-Feb-19 10:00pm GMT Thomson Reuters StreetEvents
Feb-26-19 01:52PM  Veracyte Inc (VCYT) Q4 2018 Earnings Conference Call Transcript Motley Fool +9.04%
Feb-25-19 04:15PM  Veracyte Announces Fourth Quarter and Full-Year 2018 Financial Results and Provides 2019 Financial Outlook Business Wire
03:00PM  Veracyte Inc to Host Earnings Call ACCESSWIRE
10:52AM  Veracyte Q4 Earnings Preview Benzinga
Feb-20-19 04:20PM  Veracyte Announces Participation in Upcoming Investor Conferences Business Wire
Feb-18-19 10:30AM  Will Veracyte (VCYT) Report Negative Earnings Next Week? What You Should Know Zacks
Feb-14-19 05:54PM  Veracyte CEO navigated early troubles, now has her company on path to growth American City Business Journals
Feb-06-19 11:53AM  Our Take On Veracyte, Inc.s (NASDAQ:VCYT) CEO Salary Simply Wall St.
Feb-01-19 07:50AM  Research Report Identifies Whirlpool, Adtalem Global Education, Reinsurance Group of America, W.R. Berkley, Veracyte, and 22nd Century Group with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Jan-28-19 04:20PM  Veracyte to Release Fourth Quarter and Full-Year 2018 Financial Results February 25, 2019 Business Wire
Jan-09-19 04:30PM  Veracyte to Present at the 21st Annual Needham Growth Conference Business Wire
Jan-03-19 09:54AM  Can the nose point the way to early lung cancer detection? This Peninsula company's Big Pharma deal aims to find out American City Business Journals +9.08%
07:00AM  Veracyte Announces Strategic Collaboration with Johnson & Johnson Innovation in Battle Against Lung Cancer Business Wire
Jan-02-19 05:54PM  Veracyte to Present at the 37th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-05-18 07:30AM  Veracyte Announces Expansion of Envisia Genomic Classifier Early Access Program Business Wire
Nov-23-18 08:55AM  Investor Expectations to Drive Momentum within Cel-Sci, DGSE Companies, Veracyte, China Pharma, Barnwell Industries, and Silvercrest Asset Management Group Discovering Underlying Factors of Influence GlobeNewswire
Nov-09-18 08:30AM  Veracyte to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum Business Wire
Nov-08-18 04:24PM  Veracyte Announces Publication of Data Demonstrating Real World Performance of Afirma GSC in Thyroid Cancer Diagnosis Business Wire +5.92%
Nov-01-18 11:07AM  Edited Transcript of VCYT earnings conference call or presentation 29-Oct-18 8:30pm GMT Thomson Reuters StreetEvents -12.39%
Oct-31-18 12:00PM  3 Healthcare Stocks Leading New Industry Trends ACCESSWIRE +28.46%
Oct-30-18 05:27PM  Here's Why Veracyte Jumped 22.5% Higher Today Motley Fool +22.46%
Oct-29-18 06:10PM  Veracyte (VCYT) Reports Q3 Loss, Tops Revenue Estimates Zacks
05:07PM  Veracyte: 3Q Earnings Snapshot Associated Press
04:05PM  Veracyte Announces Third Quarter 2018 Financial Results Business Wire
07:44AM  Q3 Earnings Preview For Veracyte Benzinga
Oct-22-18 10:31AM  Veracyte (VCYT) Q3 Earnings Preview: Here's What to Look Out For Zacks
Oct-15-18 04:20PM  Veracyte to Host Conference Call and Webcast to Discuss Third Quarter 2018 Financial Results on Monday, October 29, 2018 Business Wire
Oct-09-18 04:05PM  Veracyte Announces Presentation of Real World Clinical Utility Data at CHEST 2018 Showing Percepta Classifier Reduces Invasive Procedures in Lung Cancer Diagnosis Business Wire
Oct-08-18 04:05PM  Veracyte Announces Presentation of Data Confirming Envisia Genomic Classifiers Ability to Improve Diagnosis of Idiopathic Pulmonary Fibrosis Business Wire
Oct-06-18 01:50PM  Veracyte Announces that New Data from Multiple Studies Demonstrate Real World Performance of Afirma GSC and Xpression Atlas in Thyroid Cancer Diagnosis Business Wire
Oct-05-18 08:38PM  Versant Venture Management, LLC Buys Veracyte Inc GuruFocus.com
Sep-27-18 04:05PM  Veracyte to Present at the Cantor Fitzgerald Global Healthcare Conference Business Wire
08:15AM  Veracyte Announces New Data Reinforcing Clinical Value of Genomic Tests In Lung Disease Diagnoses to Be Presented at CHEST Annual Meeting 2018 Business Wire
Sep-26-18 08:15AM  Veracyte Announces Multiple Studies to Be Presented at ATA Annual Meeting Demonstrating Real World Performance of Afirma GSC and Xpression Atlas in Thyroid Cancer Diagnosis Business Wire -7.48%
Sep-10-18 03:18PM  Is Veracyte Inc (NASDAQ:VCYT) A Healthcare Industry Laggard Or Leader? Simply Wall St.
Aug-31-18 08:29AM  The Daily Biotech Pulse: FDA Blessings for Merck's HIV Drug Combo, Veracyte's Test Gets Medicare Coverage Benzinga
Aug-30-18 04:06PM  Veracyte Achieves Major Medicare Milestone for the Envisia Genomic Classifier Business Wire
08:15AM  Veracyte to Present at the Morgan Stanley 16th Annual Global Healthcare Conference Business Wire
Aug-29-18 04:05PM  Veracyte Names Angeline McCabe as Vice President, Investor Relations and Corporate Communications Business Wire
Aug-13-18 08:45AM  Implied Volatility Surging for Veracyte (VCYT) Stock Options Zacks
Jul-30-18 04:15PM  Veracyte to Present at the Canaccord Genuity 38th Annual Growth Conference Business Wire
12:15PM  Veracyte Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares Business Wire
07:26AM  Zacks.com featured highlights include: OFG, Northern Oil, Sunrun, Cerus and Veracyte Zacks
Jul-27-18 08:41AM  5 Breakout Stocks Offering Stellar Returns Zacks
Jul-25-18 08:29PM  Veracyte Announces Pricing of Public Offering of 5,000,000 Shares of Common Stock Business Wire
08:41AM  Benzinga's Daily Biotech Pulse: Merck's Keytruda Found Effective, Nabriva To Acquire Zavante, FDA Denies Agile Benzinga
Jul-24-18 09:13PM  Edited Transcript of VCYT earnings conference call or presentation 23-Jul-18 8:30pm GMT Thomson Reuters StreetEvents +7.14%
04:01PM  Veracyte Announces Proposed Public Offering of Common Stock Business Wire
Jul-23-18 04:09PM  Veracyte: 2Q Earnings Snapshot Associated Press
04:05PM  Veracyte Announces Second Quarter 2018 Financial Results Business Wire
02:30PM  Veracyte Inc to Host Earnings Call ACCESSWIRE
08:47AM  Earnings Preview: Veracyte Benzinga
Jul-09-18 04:05PM  Veracyte to Host Conference Call and Webcast to Discuss Second Quarter 2018 Financial Results on Monday, July 23, 2018 Business Wire
Jul-02-18 08:15AM  Veracyte Chairman and CEO to Speak at MedCity CONVERGE Business Wire
Jun-25-18 08:15AM  Veracyte Named a San Francisco Bay Area Top Workplace for Fifth Consecutive Year Business Wire
Veracyte, Inc. operates as a genomic diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas solutions for a complex landscape in thyroid nodule diagnosis to physicians; Percepta Bronchial Genomic Classifier solution for use in lung cancer diagnosis; and Envisia Genomic Classifier solution for the diagnosis of idiopathic pulmonary fibrosis. It sells its products through product specialists, account managers, and medical science specialists. Veracyte, Inc. has a strategic collaboration with Johnson & Johnson, LLC and Johnson & Johnson's Lung Cancer Initiative to advance diagnostics of a nasal swab test for early lung cancer detection; a research collaboration with Loxo Oncology for the development of therapies for patients with genetically defined cancers; and an agreement with Johnson & Johnson Services, Inc. for the development and commercialization of novel diagnostic tests to detect lung cancer. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Anderson Bonnie HChairman and CEOJun 10Option Exercise2.688,00021,440127,955Jun 11 04:36 PM
Anderson Bonnie HChairman and CEOJun 10Sale26.338,000210,635119,955Jun 11 04:36 PM
Anderson Bonnie HChairman and CEOJun 04Option Exercise2.3625,65160,536119,955Jun 05 04:21 PM
Anderson Bonnie HChairman and CEOMay 10Option Exercise2.688,00021,440103,292May 13 04:28 PM
Anderson Bonnie HChairman and CEOMay 10Sale22.998,000183,94895,292May 13 04:28 PM
Hall Christopher MPresident and COOMay 06Option Exercise7.31115,000840,775143,714May 08 04:30 PM
Hall Christopher MPresident and COOMay 06Sale25.26115,0002,904,71528,714May 08 04:30 PM
Hall Christopher MPresident and COOApr 11Option Exercise4.1880,000334,067108,714Apr 12 04:51 PM
Hall Christopher MPresident and COOApr 11Sale25.1280,0002,009,68428,714Apr 12 04:51 PM
Anderson Bonnie HChairman and CEOApr 10Option Exercise2.688,00021,440103,292Apr 11 05:17 PM
Anderson Bonnie HChairman and CEOApr 10Sale25.398,000203,08495,292Apr 11 05:17 PM
Anderson Bonnie HChairman and CEOMar 11Option Exercise2.688,00021,440110,592Mar 13 04:58 PM
Anderson Bonnie HChairman and CEOMar 11Sale19.978,000159,746102,592Mar 13 04:58 PM
Kennedy Giulia CChief Scientific & Med OfficerMar 04Option Exercise5.9817,625105,39866,249Mar 05 04:48 PM
Kennedy Giulia CChief Scientific & Med OfficerMar 04Sale20.2417,625356,70948,624Mar 05 04:48 PM
TREU JESSE IDirectorMar 04Sale20.21427,1518,632,7220Mar 04 06:03 PM
TREU JESSE IDirectorMar 01Sale20.45275,0005,623,75012,193Mar 04 06:03 PM
Kennedy Giulia CChief Scientific & Med OfficerFeb 28Option Exercise7.9937,375298,75586,775Mar 04 07:05 PM
TREU JESSE IDirectorFeb 28Sale20.50350,0007,176,40014,216Mar 04 06:03 PM
JONES EVAN/ FADirectorFeb 28Sale20.3775,0001,527,803204,653Mar 04 07:11 PM
Kennedy Giulia CChief Scientific & Med OfficerFeb 28Sale20.4537,375764,20449,400Mar 04 07:05 PM
Anderson Bonnie HChairman and CEOFeb 11Option Exercise2.688,00021,44084,541Feb 12 05:29 PM
Anderson Bonnie HChairman and CEOFeb 11Sale18.178,000145,36476,541Feb 12 05:29 PM
Anderson Bonnie HChairman and CEOJan 10Option Exercise2.688,00021,44084,541Jan 11 05:24 PM
Anderson Bonnie HChairman and CEOJan 10Sale15.668,000125,24876,541Jan 11 05:24 PM
Anderson Bonnie HChairman and CEOJan 09Option Exercise2.6817,50046,90094,041Jan 11 05:24 PM
Anderson Bonnie HChairman and CEOJan 09Sale15.1217,500264,64976,541Jan 11 05:24 PM
Anderson Bonnie HChairman and CEODec 11Option Exercise2.3624,00056,64076,541Dec 11 08:20 PM
Anderson Bonnie HChairman and CEODec 10Option Exercise2.418,00019,29860,541Dec 11 08:20 PM
Anderson Bonnie HChairman and CEODec 10Sale12.138,00097,07752,541Dec 11 08:20 PM
Anderson Bonnie HChairman and CEONov 12Option Exercise2.3623,30555,00075,846Nov 13 06:17 PM
Anderson Bonnie HChairman and CEONov 12Sale13.4223,305312,78652,541Nov 13 06:17 PM
Hall Christopher MPresident and COOOct 31Option Exercise2.6540,000106,08052,028Nov 01 05:07 PM
Hall Christopher MPresident and COOOct 31Sale13.5140,000540,27132,455Nov 01 05:07 PM
Anderson Bonnie HChairman and CEOAug 27Option Exercise2.686,00016,08058,541Aug 28 04:47 PM
Anderson Bonnie HChairman and CEOAug 27Sale12.006,00071,97152,541Aug 28 04:47 PM
Hall Christopher MPresident and COOAug 09Option Exercise2.3620,00047,20052,455Aug 10 05:10 PM
Hall Christopher MPresident and COOAug 09Sale12.0020,000240,00032,455Aug 10 05:10 PM
Anderson Bonnie HChairman and CEOAug 02Option Exercise2.6814,95040,06667,491Aug 03 04:05 PM
Anderson Bonnie HChairman and CEOAug 02Sale11.5014,950171,92552,541Aug 03 04:05 PM
TREU JESSE IDirectorAug 01Sale10.85120,0001,302,00016,804Aug 02 04:11 PM
TREU JESSE IDirectorJul 31Sale10.82380,0004,111,60017,692Aug 02 04:11 PM
Hall Christopher MPresident and COOJul 24Option Exercise0.8010,0008,00042,455Jul 24 06:14 PM
Anderson Bonnie HChairman and CEOJul 24Option Exercise2.685013452,591Jul 26 05:29 PM
Anderson Bonnie HChairman and CEOJul 24Sale11.505057552,541Jul 26 05:29 PM
Hall Christopher MPresident and COOJul 24Sale11.0010,000110,00032,455Jul 24 06:14 PM
Anderson Bonnie HChairman and CEOJul 23Option Exercise2.686,00016,08058,541Jul 24 06:12 PM
Anderson Bonnie HChairman and CEOJul 23Sale10.206,00061,17552,541Jul 24 06:12 PM
Hall Christopher MPresident and COOJul 06Option Exercise0.8032,43025,94464,885Jul 09 07:03 PM
Hall Christopher MPresident and COOJul 06Sale10.0032,430324,43932,455Jul 09 07:03 PM
Hall Christopher MPresident and COOJul 05Option Exercise0.8017,57014,05650,025Jul 09 07:03 PM
Hall Christopher MPresident and COOJul 05Sale9.9617,570174,94832,455Jul 09 07:03 PM
Anderson Bonnie HChairman and CEOJun 25Option Exercise2.416,00014,45258,541Jun 27 05:19 PM
Anderson Bonnie HChairman and CEOJun 25Sale9.266,00055,55252,541Jun 27 05:19 PM
Hall Christopher MPresident and COOJun 19Option Exercise0.809,4917,59341,946Jun 19 06:17 PM
Hall Christopher MPresident and COOJun 19Sale9.059,49185,88032,455Jun 19 06:17 PM